Each 5 mL of syrup contains Piracetam 500 mg.

Neurocetam Syrup contains Piracetam, a well-established nootropic agent that supports cognitive function by enhancing neuronal membrane fluidity, improving cerebral metabolism, and facilitating communication between nerve cells. It provides neuroprotective and vascular benefits that help maintain cognitive performance and neurological function. The syrup formulation offers a convenient alternative for patients who have difficulty swallowing tablets or capsules.

Neurocetam Syrup is indicated for the symptomatic treatment of cortical myoclonus in adult patients, irrespective of its underlying etiology. It should be used as an adjunct to other anti-myoclonic therapies to improve symptom control and support neurological function.

Piracetam acts by binding to the polar heads of phospholipids in neuronal cell membranes, restoring membrane fluidity and stability through the formation of mobile drug-phospholipid complexes. This action helps maintain the structural integrity and function of membrane proteins, thereby improving neuronal communication, synaptic transmission, and cognitive performance. In addition to its neuronal effects, Piracetam also improves cerebral microcirculation and exerts beneficial vascular effects without causing vasodilation.

The recommended dosage is 5 mL twice daily, preferably once in the morning and once in the evening. Neurocetam Syrup may be taken with or without food, or as directed by the physician.

Neurocetam Syrup is contraindicated in patients with known hypersensitivity to Piracetam, other pyrrolidone derivatives, or any component of the formulation. It should also not be administered to patients with cerebral hemorrhage, Huntington's chorea, or end-stage renal disease.